<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "verteporfin inj VIAL">
<dose><value>6</value>
</dose><route><value>IV</value>
</route><form><value>inj VIAL</value>
</form><drugname><value>verteporfin inj VIAL</value>
</drugname><strength><value>15 mg</value>
</strength><frequency><value>ONCE</value>
</frequency><instruction><value>Administer dose over 10 minutes.</value>
</instruction><volume></volume><units><value>mg/m2</value>
</units><additionalnotes><value>AHS Drug Formulary: Restricted to Specialized High Cost Drug program criteria: treatment of age-related macular degeneration in patients with predominantly (&amp;gt;50%25) subfoveal choroidal neovascularization. Must be prescribed by a Retina Specialist. </value>
</additionalnotes><population></population><indicationprn></indicationprn><backgroundinformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=3003</value>
</backgroundinformation><prninformation></prninformation><ahsformularystatus><value>Formulary with Restrictions.</value>
</ahsformularystatus><ahfsname><value>EENT Drugs, Miscellaneous</value>
</ahfsname><highalert></highalert><maximumprndose></maximumprndose><din><value>02242367</value>
</din><type><value>Medication/IV Therapy</value>
</type></drug>